These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 11465965

  • 1. Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy.
    Briguori C, Betocchi S, Manganelli F, Gigante B, Losi MA, Ciampi Q, Gottilla R, Violante A, Tocchetti CG, Volpe M, Chiariello M.
    Eur Heart J; 2001 Aug; 22(15):1328-36. PubMed ID: 11465965
    [Abstract] [Full Text] [Related]

  • 2. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
    Thaman R, Esteban MT, Barnes S, Gimeno JR, Mist B, Murphy R, Collinson PO, McKenna WJ, Elliott PM.
    Am J Cardiol; 2006 Aug 15; 98(4):515-9. PubMed ID: 16893708
    [Abstract] [Full Text] [Related]

  • 4. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
    Faludi R, Tóth L, Pótó L, Cziráki A, Simor T, Papp L.
    Orv Hetil; 2005 Jan 02; 146(1):23-6. PubMed ID: 15715369
    [Abstract] [Full Text] [Related]

  • 5. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
    Panou FK, Kotseroglou VK, Lakoumentas JA, Chrysanthopoulou SA, Armeniakos JA, Stratigou T, Veve H, Zacharoulis AA.
    Hellenic J Cardiol; 2006 Jan 02; 47(6):344-51. PubMed ID: 17243506
    [Abstract] [Full Text] [Related]

  • 6. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM, Fahrleitner A, Watzinger N, Fruhwald S, Dobnig H, Schumacher M, Maier R, Zweiker R, Klein WW.
    Eur Heart J; 1999 Oct 02; 20(19):1415-23. PubMed ID: 10487802
    [Abstract] [Full Text] [Related]

  • 7. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
    Kim SW, Park SW, Lim SH, Kwon SU, Choi YJ, Park MK, Lee SC, Lee SH, Park JE, Jeon ES.
    Clin Cardiol; 2006 Apr 02; 29(4):155-60. PubMed ID: 16649724
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determinants of elevated NT-proBNP levels in patients with hypertrophic cardiomyopathy: an echocardiographic study.
    Kahveci G, Bayrak F, Mutlu B, Basaran Y.
    Heart Lung Circ; 2009 Aug 02; 18(4):266-70. PubMed ID: 19157978
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E, Araujo AQ, Buck P, Ianni BM, Rabello R, Mady C.
    Am Heart J; 2005 Dec 02; 150(6):1228-32. PubMed ID: 16338263
    [Abstract] [Full Text] [Related]

  • 15. B-type natriuretic peptide after percutaneous transluminal septal myocardial ablation.
    Sakamoto T, Mizuno Y, Ogawa H, Yoshimura M, Kugiyama K, Yasue H.
    Int J Cardiol; 2002 May 02; 83(2):151-8. PubMed ID: 12007687
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.